A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

NCT00996580 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3597

Enrollment

INDUSTRY

Sponsor class

Conditions

Pregnancy Prevention

Interventions

DRUG: DR-103

Sponsor

Teva Women's Health